Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing
- PMID: 325150
- DOI: 10.1093/infdis/135.6.970
Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing
Abstract
The susceptibilities of 216 isolates of pathogenic and commensal yeasts to 5-fluorocytosine were tested by a disk diffusion technique with use of 1- and 10-microgram disks. Minimal inhibitory concentrations (MICs) were determined by an agar dilution procedure with yeast morphology agar, pH 5.0, supplemented with 0.25 mg of thiamine/dl. Zones of inhibition produced by the two disks were correlated with paired MIC values. An MIC of 16 micrograms/ml, the upper limit of probable clinical susceptibility, correlated with zones of 14 mm and 25 mm, respectively, for the 1- and 10-microgram disks. With these values as interpretative breakpoints, the 1-microgram disk would have failed to predict clinical susceptibility with 25% of the suceptible isolates of Candida species other than Candida albicans, with 14% of the susceptible isolates of Cryptococcus neoformans, with 7% of the susceptible isolates of C. albicans, and with one of the 25 susceptible isolates of Torulopsis glabrata. The 10-microgram disk would have failed to predict susceptibility with only two isolates of Candida species.
Similar articles
-
Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.Am J Clin Pathol. 1979 Aug;72(2):194-8. doi: 10.1093/ajcp/72.2.194. Am J Clin Pathol. 1979. PMID: 382827
-
In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.Chemotherapy. 1991;37(1):23-31. doi: 10.1159/000238828. Chemotherapy. 1991. PMID: 2013239
-
In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.Rev Iberoam Micol. 2004 Jun;21(2):63-9. Rev Iberoam Micol. 2004. PMID: 15538829
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Antifungal drug resistance in pathogenic fungi.Med Mycol. 1998;36 Suppl 1:119-28. Med Mycol. 1998. PMID: 9988500 Review.
Cited by
-
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.J Clin Microbiol. 1986 Feb;23(2):298-301. doi: 10.1128/jcm.23.2.298-301.1986. J Clin Microbiol. 1986. PMID: 3517051 Free PMC article.
-
Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.Antimicrob Agents Chemother. 1982 Sep;22(3):482-7. doi: 10.1128/AAC.22.3.482. Antimicrob Agents Chemother. 1982. PMID: 6753737 Free PMC article.
-
Evaluation of five commercial antifungal susceptibility testing systems.Eur J Clin Microbiol Infect Dis. 1993 May;12(5):336-42. doi: 10.1007/BF01964429. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8354299
-
Antifungal susceptibility testing.Clin Microbiol Rev. 1993 Oct;6(4):367-81. doi: 10.1128/CMR.6.4.367. Clin Microbiol Rev. 1993. PMID: 8269392 Free PMC article. Review.
-
Ketoconazole resistance in Torulopsis glabrata.Mycopathologia. 1989 Jul;107(1):51-5. doi: 10.1007/BF00437589. Mycopathologia. 1989. PMID: 2811982
MeSH terms
Substances
LinkOut - more resources
Full Text Sources